Back
Aurinia Pharmaceuticals Vs. Grace Therapeutics Industry Stock Comparison
Sell
46
AUPH
Aurinia Pharmaceuticals
Last Price:
7.21
Seasonality Move:
24.32%
Sell
39
GRCE
Grace Therapeutics
Last Price:
3.08
Seasonality Move:
7.4%
Sell
46
Aurinia Pharmaceuticals (AUPH)
is a Sell
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
- The current Aurinia Pharmaceuticals [AUPH] share price is $7.21. The Score for AUPH is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- AUPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Grace Therapeutics (GRCE)
is a Sell
Is Grace Therapeutics a Buy, Sell or Hold?
- The current Grace Therapeutics [GRCE] share price is $3.14. The Score for GRCE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- GRCE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $7.21
The current trend is moderately bullish and AUPH is experiencing slight buying pressure.
GRCE Stock Price Chart
What is Grace Therapeutics's stock price today?
-
The Grace Therapeutics share price today is $3.14
The current trend is moderately bearish and GRCE is experiencing slight buying pressure.
AUPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 53.16 | Buy |
| Chaikin Money Flow: | 525662 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.95 - 7.29) | Buy |
| Bollinger Bands (100): | (5.6 - 7.08) | Buy |
GRCE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 49.29 | Sell |
| Chaikin Money Flow: | -25 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.08 - 3.38) | Sell |
| Bollinger Bands (100): | (2.52 - 3.2) | Buy |
AUPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.24 | Sell |
| 20-day SMA: | 7.11 | Buy |
| 50-day SMA: | 7.03 | Buy |
| 200-day SMA: | 6.07 | Buy |
| 8-day EMA: | 7.24 | Sell |
| 20-day EMA: | 7.16 | Buy |
| 50-day EMA: | 6.91 | Buy |
| 200-day EMA: | 6.64 | Buy |
GRCE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.21 | Sell |
| 20-day SMA: | 3.27 | Sell |
| 50-day SMA: | 2.92 | Buy |
| 200-day SMA: | 2.93 | Buy |
| 8-day EMA: | 3.19 | Sell |
| 20-day EMA: | 3.19 | Sell |
| 50-day EMA: | 3.03 | Buy |
| 200-day EMA: | 2.9 | Buy |
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and an increase next year of $0.36 per share.
Grace Therapeutics Earnings Growth & GRCE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.16 per share, and a decrease next year of $0.01 per share.
Aurinia Pharmaceuticals Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Grace Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||